Ho‐Young Lee

13.6k total citations · 1 hit paper
296 papers, 10.1k citations indexed

About

Ho‐Young Lee is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ho‐Young Lee has authored 296 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Molecular Biology, 60 papers in Oncology and 46 papers in Cancer Research. Recurrent topics in Ho‐Young Lee's work include Growth Hormone and Insulin-like Growth Factors (32 papers), Cancer, Hypoxia, and Metabolism (32 papers) and PI3K/AKT/mTOR signaling in cancer (24 papers). Ho‐Young Lee is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (32 papers), Cancer, Hypoxia, and Metabolism (32 papers) and PI3K/AKT/mTOR signaling in cancer (24 papers). Ho‐Young Lee collaborates with scholars based in South Korea, United States and Ethiopia. Ho‐Young Lee's co-authors include Waun Ki Hong, Hye‐Young Min, Floriana Morgillo, Edward S. Kim, Jonathan M. Kurie, Jong Kyu Woo, Fadlo R. Khuri, Jennifer A. Doudna, Pinchas Cohen and Chaitan Khosla and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Ho‐Young Lee

276 papers receiving 9.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular targeted therapy for anticancer treatment

2022 255 citations Hye‐Young Min, Ho‐Young Lee profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ho‐Young Lee South Korea	54	6.0k	2.1k	1.9k	1.2k	1.1k	296	10.1k
Debashis Ghosh United States	42	6.3k 1.1×	1.8k 0.8×	1.9k 1.0×	1.7k 1.4×	362 0.3×	244	11.2k
Jong‐Il Kim South Korea	54	5.2k 0.9×	1.3k 0.6×	1.3k 0.7×	1.1k 0.9×	650 0.6×	436	11.9k
Joseph M. Smith United States	46	5.7k 1.0×	1.6k 0.7×	1.1k 0.6×	935 0.8×	650 0.6×	141	12.9k
Aik Choon Tan United States	56	6.8k 1.1×	4.5k 2.1×	2.8k 1.5×	2.0k 1.6×	564 0.5×	262	12.1k
Xin Chen China	58	6.6k 1.1×	2.2k 1.0×	3.2k 1.7×	1.1k 0.9×	303 0.3×	382	11.7k
Yutaka Yatomi Japan	63	9.9k 1.7×	1.3k 0.6×	727 0.4×	932 0.8×	584 0.5×	504	16.1k
Lin Yang China	45	3.6k 0.6×	1.4k 0.7×	1.5k 0.8×	1.6k 1.4×	249 0.2×	317	7.4k
Isabelle Salmon Belgium	57	3.9k 0.7×	2.7k 1.2×	1.6k 0.8×	1.6k 1.3×	546 0.5×	352	11.2k
Craig Robson United Kingdom	58	7.1k 1.2×	2.4k 1.1×	1.5k 0.8×	2.2k 1.8×	400 0.3×	197	9.6k
Róbert Kiss Belgium	74	8.8k 1.5×	2.7k 1.2×	1.6k 0.8×	1.0k 0.8×	485 0.4×	478	17.8k

Countries citing papers authored by Ho‐Young Lee

Since Specialization

Citations

This map shows the geographic impact of Ho‐Young Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho‐Young Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho‐Young Lee more than expected).

Fields of papers citing papers by Ho‐Young Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ho‐Young Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho‐Young Lee. The network helps show where Ho‐Young Lee may publish in the future.

Co-authorship network of co-authors of Ho‐Young Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Ho‐Young Lee. A scholar is included among the top collaborators of Ho‐Young Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ho‐Young Lee. Ho‐Young Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Noh, Myungkyung, Hye‐Young Min, Jong-Uk Lee, et al.. (2023). Particulate matter-induced metabolic recoding of epigenetics in macrophages drives pathogenesis of chronic obstructive pulmonary disease. Journal of Hazardous Materials. 464. 132932–132932. 12 indexed citations

Le, Huong Thuy, Ho Jin Lee, Ho Jin Lee, et al.. (2021). Insulin-Like Growth Factor Binding Protein-3 Exerts Its Anti-Metastatic Effect in Aerodigestive Tract Cancers by Disrupting the Protein Stability of Vimentin. Cancers. 13(5). 1041–1041. 14 indexed citations

Cho, Jaebeom, Hye‐Young Min, Xuan Wei, et al.. (2020). The ATF6-EGF Pathway Mediates the Awakening of Slow-Cycling Chemoresistant Cells and Tumor Recurrence by Stimulating Tumor Angiogenesis. Cancers. 12(7). 1772–1772. 22 indexed citations

Yoon, Joon‐Kee, et al.. (2020). Cell cycle synchronisation using thiazolidinediones affects cellular glucose metabolism and enhances the therapeutic effect of 2-deoxyglucose in colon cancer. Scientific Reports. 10(1). 4713–4713. 4 indexed citations

Zhang, Yanli, Qing Li, Fang Fang, et al.. (2018). SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin–Rho GTPase–Hippo Pathways. Cancer Research. 78(9). 2305–2317. 119 indexed citations

Park, Ji Eun, Derek Reichel, Jee Sun Min, et al.. (2017). Polymer micelle formulation for the proteasome inhibitor drug carfilzomib: Anticancer efficacy and pharmacokinetic studies in mice. PLoS ONE. 12(3). e0173247–e0173247. 33 indexed citations

Lee, Ho Jin, et al.. (2016). Chronic Stress Facilitates Lung Tumorigenesis by Promoting Exocytosis of IGF2 in Lung Epithelial Cells. Cancer Research. 76(22). 6607–6619. 50 indexed citations

Min, Hye‐Young, Su-Chan Lee, Jong Kyu Woo, et al.. (2016). Essential Role of DNA Methyltransferase 1–mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors. Clinical Cancer Research. 23(5). 1299–1311. 21 indexed citations

Kim, Jin‐Soo, Su-Chan Lee, Hye‐Young Min, et al.. (2015). Activation of insulin-like growth factor receptor signaling mediates resistance to histone deacetylase inhibitors. Cancer Letters. 361(2). 197–206. 12 indexed citations

10.

Shin, Dong Hoon, Hye‐Young Min, Adel K. El‐Naggar, et al.. (2011). Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin–like Growth Factor I Receptor Monoclonal Antibody. Molecular Cancer Therapeutics. 10(12). 2437–2448. 37 indexed citations

11.

Kim, Woo‐Young, Mi-Jung Kim, Hojin Moon, et al.. (2011). Differential Impacts of Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3) in Epithelial IGF-Induced Lung Cancer Development. Endocrinology. 152(6). 2164–2173. 19 indexed citations

12.

Ha, Hyekyung, Jun Kyoung Lee, Ho‐Young Lee, et al.. (2011). Genotoxicity assessment of a herbal formula, Ojeok-san. Journal of Ethnopharmacology. 135(2). 586–589. 14 indexed citations

13.

Jung, Da-Young, Hyekyung Ha, Ho‐Young Lee, et al.. (2010). Stimulation of the Immune Response by Yanggyuksanhwa-tang. Journal of Sasang Constitutional Medicine. 22(4). 77–84. 4 indexed citations

14.

Lee, Jin‐Ah, Hyekyung Ha, Da-Young Jung, et al.. (2010). Anti-inflammatory Effects of Sam-chul-kun-bi-tang. 31(3). 47–54. 4 indexed citations

15.

Lee, Jin‐Ah, et al.. (2010). Comparative Study of 25 Herbal Formulas on Anti-Inflammatory Effect. The Journal of Korean Obstetrics and Gynecology. 23(3). 101–111. 6 indexed citations

16.

Kim, Woo‐Young, Seung Hyun Oh, Jong Kyu Woo, Waun Ki Hong, & Ho‐Young Lee. (2009). Targeting Heat Shock Protein 90 Overrides the Resistance of Lung Cancer Cells by Blocking Radiation-Induced Stabilization of Hypoxia-Inducible Factor-1α. Cancer Research. 69(4). 1624–1632. 112 indexed citations

17.

Kim, Woo-Young, Quanri Jin, Edward S. Kim, et al.. (2009). Elevated Epithelial Insulin-like Growth Factor Expression Is a Risk Factor for Lung Cancer Development. Cancer Research. 69(18). 7439–7448. 60 indexed citations

18.

Kim, Woo‐Young, Dong Chang, Bryan T. Hennessy, et al.. (2008). A Novel Derivative of the Natural Agent Deguelin for Cancer Chemoprevention and Therapy. Cancer Prevention Research. 1(7). 577–587. 49 indexed citations

19.

Morgillo, Floriana, Jong Kyu Woo, Edward S. Kim, Waun Ki Hong, & Ho‐Young Lee. (2006). Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib. Cancer Research. 66(20). 10100–10111. 275 indexed citations

20.

Hwang, Jun‐Won, et al.. (2006). Regional cerebral perfusion abnormalities in developmental language disorder. European Archives of Psychiatry and Clinical Neuroscience. 256(3). 131–137. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact